Abstract
Diabetes Retinopathy is an important microvascular complication of diabetes mellitus and estimation of the retinopathy prevalence from cross sectional data is very important. This study is to estimate the hazard rate of diabetic retinopathy when only cross sectional data measuring diabetes prevalence is available. A total of 459 type 2 diabetic patients referred to an Ophthalmology clinic from May to December 2008 were studied. The severity of diabetic retinopathy was graded as per Early Treatment Diabetic Retinopathy Study (ETDRS). Factors associated with occurrence of retinopathy were assessed by the Cox’s proportional hazard model for current status data. Multivariate analysis showed that body mass index, gender, smoking status and family history of diabetes were more independent predictions of diabetic retinopathy, while method of treatment, history of hypertension and duration of diabetes were all significantly associated with the occurrence of diabetic retinopathy. Compared with oral treatment group, those on insulin were more likely to be associated with diabetic retinopathy. From the cross sectional data, it is concluded that diabetic retinopathy hazard rate are less in patients with hypertension and more in patients using insulin and those with long duration of diabetes.
Similar content being viewed by others
References
Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179–83.
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study; Part III: prevalence and risk of diabetic retinopathy when age at diagnosis is thirty or more years. Arch Ophthalmol. 1984;102:527–33.
Fong DS, Aiello L, Gardener TW, King GL, et al. Retinopathy in diabetes. Diabetes Care. 2004;27:84–7.
Semeraro F, Parrinello G, Cancarini A, Pasquini L, Zarra E, Cimino A, et al. Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabet Complicat. 2011;25:292–7.
Henschel V, Heiss C, Mansmann U. Intcox: Iterated Convex Minorant Algorithm for interval censored event data. 2009. http://cran.r-project.org/web/packages/intcox/index.html. Accessed 6 July 2009
Sun J. The statistical analysis of interval-censored failure time data. New York: Springer; 2006.
Wang L, Sun J, Tong X. Efficient estimation for the proportional hazards model with bivariate current status data. Lifetime Data Anal. 2008;14:134–53.
Javadi MA, Katibeh M, Dehghan MH, et al. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol. 2009;9:12.
Afkhami-Ardekani M, Modrresi M, Amirchaghmaghi E. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol. 2008;18:112–7.
Jamal-u-Din A, Qureshi MB, Khan AJ, Khan MD, Ahmad K. Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan. J Ayub Med Coll. 2006;18:40–3.
Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. Br J Ophthalmol. 2002;86:1014–8.
Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Mathews DR, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent sk factors. Arch Ophthalmol. 1998;116:297–303.
Varma R, Torres M, Pena F, Klein R, Azen SP. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1298–306.
Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIV (1994) ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217–28.
Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol. 1998;42:535–47.
van Leiden HA, Dekker JM, Moll AC, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol. 2003;121:245–51.
Kempen JH, O’Colmain BJ, Lesk MC, Haffner SM, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552–63.
Dowse GK, Humphrey AR, Collins VR, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147:448–57.
Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol. 2007;52:180–95.
Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med. 1997;157:650–6.
West KM, Erdreich LJ, Stober JA. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 1980;29:501–8.
Chaturvedi N, Fuller JH. Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care. 1995;18:766–74.
Chen MS, Kao CS, Chang CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114:723–30.
Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol. 1999;83:937–40.
Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care. 2003;26:320–6.
Manaviat MR, Rashidi M, Afkhami-Ardekani M. Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes. Eur J Ophthalmol. 2008;18:572–7.
Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care. 2002;25:134–47.
Whalent KL, Stewart RD. Pharmacologic management of hypertension in patients with diabetes. Am Fam Physician. 2008;78:1277–82.
Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in long standing IDDM. Diabetes. 1989;38:460–4.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–13.
Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086–97.
Acknowledgments
The authors would like to thank all the patient participants in this study and the staff of Yazd Diabetes Research Center who helped us in collecting data.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Askarishahi, M., Hajizadeh, E., Afkhami-Ardekani, M. et al. Estimate of the diabetic retinopathy hazard rates in type 2 diabetic patients with current status data. Int J Diabetes Dev Ctries 32, 203–208 (2012). https://doi.org/10.1007/s13410-012-0092-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-012-0092-0